Regulatory Hurdles Facing Psychedelics
Market introduction of psychedelics as a therapy looks promising. However, policy and regulatory issues concerning the drug class still exist.
Articles by Shane O'Connor, MS
DMT: The Biosynthesis Debate
New research provides insight into the debate centered around the brain's capacity to synthesize DMT endogenously.
Psychedelics: A New Treatment For Disorders of Consciousness?
A look into the potential therapeutic application of psychedelics in disorders of consciousness.
Oakland Takes First Steps Toward Decriminalization
Oakland activists arrange May 28 meeting with the city council to discuss decriminalizing entheogens.
Psychedelics as a Performance-Enhancer in Athletics
A look into the cognitive-enhancing effects of psychedelics in sports.
Exploring the Potential Recreational Psilocybin Market
Scientific and public opinion is slowly shifting for the potential usage of psilocybin in a variety of conditions. Can the same be said for recreational usage?
Analysis of the Future Psilocybin Pharmaceutical Market
FDA approval for psilocybin-assisted therapy for depression appears to be on the horizon.